Thyroid hormones and mortality risk in euthyroid individuals: The Kangbuk Samsung health study

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 7, 2014, Pages 2467-2476

  Zhang, Yiyi ^a   Chang, Yoosoo ^a,b   Ryu, Seungho ^a,b   Cho, Juhee ^a,b,c   Lee, Won Young ^b   Rhee, Eun Jung ^b   Kwon, Min Jung ^b   Pastor Barriuso, Roberto ^d   Rampal, Sanjay ^a,e   Han, Won Kon ^b   Shin, Hocheol ^b   Guallar, Eliseo ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DEATH CERTIFICATE; EUTHYROIDISM; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; KOREAN (PEOPLE); LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NORMAL VALUE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; SOUTH KOREA; THYROTROPIN BLOOD LEVEL; VITAL SIGN;

ADULT; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; REPUBLIC OF KOREA; RISK FACTORS; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES;

EID: 84904043191     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3832     Document Type: Article

References (39)

1. Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172:799-809.
2. Yang LB, Jiang DQ, Qi WB, et al. Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies. Eur J Endocrinol. 2012;167:75-84.
3. Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148:832-845. (Pubitemid 351786932)
4. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365-1374.
5. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008;93:2998-3007.
6. Asvold BO, Bjoro T, Platou C, Vatten LJ. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway. Clin Endocrinol (Oxf). 2012;77:911-917.
7. Ittermann T, Haring R, Sauer S, et al. Decreased serum TSH levels are not associated with mortality in the adult northeast German population. Eur J Endocrinol. 2010;162:579-585.
8. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358:861-865. (Pubitemid 32900566)
9. Westerink J, van der Graaf Y, Faber DR, Spiering W, Visseren FL. Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases. Eur J Prev Cardiol. 2012;19:864-873.
10. Ceresini G, Ceda GP, Lauretani F, et al. Thyroid Status and 6-Year Mortality in Elderly People Living in a Mildly Iodine-Deficient Area: The Aging in the Chianti Area Study. J Am Geriatr Soc. 2013.
11. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591-2599. (Pubitemid 39577515)
12. Pereg D, Tirosh A, Elis A, et al. Mortality and coronary heart disease in euthyroid patients. Am J Med. 2012;125:826 e827-e812.
13. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SW. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab. 2005;90: 6403-6409. (Pubitemid 41759292)
14. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res. 1990;50:2283-2289. (Pubitemid 20134482)
15. Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H, Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab. 2007;92: 2190-2196. (Pubitemid 46997120)
16. Hall P, Lundell G, Holm LE. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol (Copenh). 1993; 128:230-234. (Pubitemid 23100879)
17. Bauer DC, Rodondi N, Stone KL, Hillier TA. Thyroid hormone use, hyperthyroidism and mortality in older women. Am J Med. 2007; 120:343-349. (Pubitemid 46483309)
18. Waring AC, Harrison S, Samuels MH, et al. Thyroid function and mortality in older men: a prospective study. J Clin Endocrinol Metab. 2012;97:862-870.
19. 2004 Iodine status worldwide. WHO global database on iodine deficiency. World Health Organization. http://whqlibdoc.who.int/publications/2004/ 9241592001.pdf. Accessed June 28, 2013.
20. Choi J, Kim HS, Hong DJ, Lim H, Kim JH. Urinary iodine and sodium status of urban Korean subjects: a pilot study. Clin Biochem. 2012;45:596-598.
21. Dişel U, Beşen A, Karadeniz C, et al. Prevalence of thyroid dysfunction in untreated cancer patients: a cross-sectional study. Med Oncol. 2012; 29:3608-3613.
22. Kuijpens JL, Nyklíctek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid. 2005;15:1253-1259. (Pubitemid 41821759)
23. Reddy A, Dash C, Leerapun A, et al. Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease. Clin Gastroenterol Hepatol. 2007;5:118-123. (Pubitemid 46096822)
24. Simon MS, Tang MT, Bernstein L, et al. Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev. 2002;11:1574-1578. (Pubitemid 36020009)
25. Tosovic A, Becker C, Bondeson AG, et al. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer. 2012;131:2126-2133.
26. Mondul AM, Weinstein SJ, Bosworth T, Remaley AT, Virtamo J, Albanes D. Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer. PLoS One. 2012;7:e47730.
27. Hellevik AI, Asvold BO, Bjøro T, et al. Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev. 2009;18:570-574.
28. Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012;133:1169-1177.
29. Razvi S, Weaver JU, Butler TJ, Pearce SH. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 2012;172:811-817.
30. Hassan MM, Kaseb A, Li D, et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology. 2009;49:1563-1570.
31. Liangpunsakul S, Chalasani N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? J Clin Gastroenterol. 2003;37:340-343. (Pubitemid 37158998)
32. Ittermann T, Haring R, Wallaschofski H, et al. Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. Thyroid. 2012;22:568-574.
33. Sar P, Peter R, Rath B, Das Mohapatra A, Mishra SK. 3, 3′5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements. PLoS One. 2011;6:e20861.
34. Dentice M, Luongo C, Ambrosio R, et al. β-Catenin regulates de-iodinase levels and thyroid hormone signaling in colon cancer cells. Gastroenterology. 2012;143:1037-1047.
35. Upadhyay G, Singh R, Kumar A, Kumar S, Kapoor A, Godbole MM. Severe hyperthyroidism induces mitochondria-mediated apoptosis in rat liver. Hepatology. 2004;39:1120-1130. (Pubitemid 38428951)
36. Moriggi G, Verga Falzacappa C, Mangialardo C, et al. Thyroid hormones (T3 and T4): dual effect on human cancer cell proliferation. Anticancer Res. 2011;31:89-96.
37. Türemen EE, Çetinarslan B, Şahin T, Cantürk Z, Tarkun İ. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J. 2011; 58:349-354.
38. Muñoz A, Bernal J. Biological activities of thyroid hormone receptors. Eur J Endocrinol. 1997;137:433-445. (Pubitemid 27505301)
39. Takamura N, Akilzhanova A, Hayashida N, et al. Thyroid function is associated with carotid intima-media thickness in euthyroid subjects. Atherosclerosis. 2009;204:e77-e81.